2022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
The Nobel Prize recently shared an encouraging post on LinkedIn:
”A personal message from 2022 chemistry laureate Carolyn Bertozzi to all young researchers on why to aspire to a career in science:
‘I would want to share with them how a life in science is incredibly rewarding. It is rewarding because it is creative. You are discovering knowledge and gifting that to humanity for all of posterity. Once you learn something no one can take that away. It is not an object. It is an intellectual currency that will be shared throughout the generations. And you created that. It has a permanence that ironically a physical object doesn’t have. You can paint a painting, but eventually it will fade. But knowledge doesn’t fade. Knowledge stays with us forever and it becomes the foundation for the next generations.’ ”
In this personal message to aspiring researchers, Nobel laureate Carolyn Bertozzi emphasized the creativity and lasting impact of a life in science.
She encourages young scientists to pursue discovery, highlighting that knowledge is a permanent gift to humanity, unlike physical creations that may fade over time.
Carolyn Bertozzi describes scientific knowledge as an intellectual currency that endures across generations, forming the foundation for future discoveries.
More winner stories in the field of Science featured in Hemostasis Today.
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 16, 2025, 14:58Donate Today to Advance Thrombosis Awareness and Research
-
Jul 16, 2025, 14:57ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
-
Jul 16, 2025, 14:52ASH Expands Access to Educational Resources in LMICs
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 15, 2025, 18:24Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
-
Jul 15, 2025, 15:48Managing CVT in Pregnancy: Balancing Risks and the Role of Antithrombotic Prophylaxis
-
Jul 15, 2025, 07:37Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding - Blood Journals Portfolio
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems